Dr. Joe Gray, Ph.D., is now Professor Emeritus at OHSU. This is his former lab page.
The overarching goal in the Gray Laboratory is to develop more durable and tolerable control of advanced breast and pancreatic cancers. Current studies are carried out as part of collaborative team oriented projects led or co-led by Dr. Gray. These include:
- An NCI Cancer Systems Biology Consortium Center that aims to develop a systems-level understanding of how tumor intrinsic and extrinsic factors work together to enable triple-negative breast cancer to escape therapeutic control and devise robust control strategies.
- An NCI Human Tumor Atlas Network (HTAN) Research Center that performs comparative omic and multiscale image analyses of responsive and resistant lesions within individual metastatic breast cancer patients to discover mechanisms of resistance so they can be attacked therapeutically.
- The Serial Measurement of Molecular and Architectural Responses to Therapy (SMMART) Program that focuses on identification of therapeutic vulnerabilities in advanced individual cancers of the breast, prostate, pancreas and AML become resistant to treatment in order to guide development of more durable and tolerable treatments.
- An NIH Library of Integrated Network-based Cellular Signatures (LINCS) Center that aimed to develop datasets and computational strategies to elucidate how microenvironmental signals affect cell intrinsic intracellular transcriptional and protein defined molecular networks to generate experimentally observable phenotypes.